Profound Medical Corp.

PROF · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus
180
SEC Filings

Business Summary

Profound Medical Corp. is a commercial-stage medical device company focused on AI-powered, MRI-guided, incision-free therapies for ablation of diseased tissue. Its lead product, TULSA-PRO, uses real-time MRI, robotically-driven transurethral ultrasound, and closed-loop temperature feedback to ablate prostate tissue for cancer and BPH. Its Sonalleve system treats uterine fibroids, bone metastases, osteoid osteoma, and benign desmoid tumors. The company generates revenue from capital equipment sales and recurring one-time-use disposable devices.

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPROFdiscussed_in_filing Artificial Intelligence
topic_mentionPROFdiscussed_in_filing Cybersecurity
topic_mentionPROFdiscussed_in_filing Trusted Computing
topic_mentionPROFdiscussed_in_filing Blockchain & Crypto
topic_mentionPROFdiscussed_in_filing Robotics
topic_mentionPROFdiscussed_in_filing Regulation
topic_mentionPROFdiscussed_in_filing Healthcare & Bio
topic_mentionPROFdiscussed_in_filing Platform & Ecosystem
topic_mentionPROFdiscussed_in_filing Sovereign & Government
topic_mentionPROFdiscussed_in_filing Artificial Intelligence
topic_mentionPROFdiscussed_in_filing Cybersecurity
topic_mentionPROFdiscussed_in_filing Trusted Computing
topic_mentionPROFdiscussed_in_filing Blockchain & Crypto
topic_mentionPROFdiscussed_in_filing Robotics
topic_mentionPROFdiscussed_in_filing Regulation
topic_mentionPROFdiscussed_in_filing Healthcare & Bio
topic_mentionPROFdiscussed_in_filing Platform & Ecosystem
topic_mentionPROFdiscussed_in_filing Sovereign & Government
topic_mentionPROFdiscussed_in_filing Artificial Intelligence
topic_mentionPROFdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001104659-26-024153EDGAR92K words
2025-03-072024-12-310001410578-25-000300EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001104659-25-111378EDGAR17K words
2025-08-142025-06-300001410578-25-001809EDGAR—
2025-05-082025-03-310001410578-25-001112EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001171843-26-002146EDGAR1K words
2026-03-270001171843-26-001971EDGAR—
2026-03-130001171843-26-001553EDGAR—
2026-03-100001104659-26-025822EDGAR—
2026-03-090001171843-26-001406EDGAR—
2026-03-050001171843-26-001362EDGAR—
2026-02-120001171843-26-000791EDGAR—
2026-02-120001171843-26-000772EDGAR—
2026-02-050001171843-26-000643EDGAR—
2026-01-280001171843-26-000450EDGAR—

180 total filings indexed. 165 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

MMM — 3M CO ARAY — ACCURAY INC AEMD — AETHLON MEDICAL INC ALUR — ALLURION TECHNOLOGIES, INC. ANGO — ANGIODYNAMICS INC AORT — ARTIVION, INC. RCEL — AVITA Medical, Inc. ADGM — Adagio Medical Holdings, Inc.

Tags

prostate-cancer-treatment benign-prostatic-hyperplasia-(bph)-treatment uterine-fibroid-treatment bone-metastases-palliative-care osteoid-osteoma-treatment benign-desmoid-tumor-management mri-thermometry closed-loop-temperature-feedback-control focused-ultrasound ce-mark fda-class-ii-clearance hde-(humanitarian-device-exemption)

Company Identity

CIK0001628808
TickerPROF
ExchangeNasdaq
SIC3841: Surgical & Medical Instruments & Apparatus
IncorporatedA6

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f7cb4278a71e7bdeb251af294557859ebb855829de1b02661e9cd0a1500f81d2
parent: dcfd7e56e663a21b5ab5b4b2a9ad92fb75c35f6b7bd4f5c4379131503e3e670a
content hash: 532a4a36bb414185fe67d0fd1a0e6d77e55fdf6ae8c44f8742bda60157912465
signed: 2026-04-13T04:47:00.270Z
sources: 5 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf